Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
Iovance Biotherapeutics(IOVA) stock is priced at $3.71, giving the company a market capitalization of 1.52B. It carries a P/E multiple of -3.29.
On 2026-03-27, Iovance Biotherapeutics(IOVA) stock traded between a low of $3.53 and a high of $3.81. Shares are currently priced at $3.71, which is +5.1% above the low and -2.6% below the high.
The Iovance Biotherapeutics(IOVA)'s current trading volume is 7.47M, compared to an average daily volume of 13.12M.
During the past year, Iovance Biotherapeutics(IOVA) stock moved between $1.64 at its lowest and $5.63 at its peak.
During the past year, Iovance Biotherapeutics(IOVA) stock moved between $1.64 at its lowest and $5.63 at its peak.
IOVA News
Iovance Biotherapeutics ( (IOVA) ) just unveiled an update. On March 17, 2026, Iovance Biotherapeutics announced that board member Wendy Yarno will retire from...
Analyst ratings
73%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.